C
West Pharmaceutical Services, Inc. WST
$230.11 $6.382.85%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)
Weiss Ratings WST - NYSE Click to
Compare
Click to
Compare
Click to
Compare
Rating C
Reward Index Fair
Risk Index Weak
Risk Grade D
Reward Grade C
Rating Factors WST - NYSE Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index Weak
Growth Index Fair
Efficiency Index Excellent
Solvency Index Excellent
Total Return Index Weak
Volatility Index Weak
Beta / Standard Deviation WST - NYSE Click to
Compare
Click to
Compare
Click to
Compare
Beta 0.42
Price History WST - NYSE Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return -1.14%
30-Day Total Return -32.59%
60-Day Total Return -30.35%
90-Day Total Return -27.20%
Year to Date Total Return -29.89%
1-Year Total Return -40.49%
2-Year Total Return -29.00%
3-Year Total Return -39.86%
5-Year Total Return 78.48%
52-Week High % Change -42.60%
52-Week Low % Change 16.80%
Price WST - NYSE Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $400.88
52-Week Low Price $197.01
52-Week Low Price (Date) Feb 13, 2025
52-Week High Price (Date) Mar 21, 2024
Valuation WST - NYSE Click to
Compare
Click to
Compare
Click to
Compare
Market Cap 16.64B
Enterprise Value 16.46B
Price/Earnings (TTM) 34.38
Earnings Per Share (TTM) 6.69
Earnings Per Share Growth -14.97%
Price/Earnings To Growth --
Price/Sales (TTM) 5.83
Price/Book (Q) 6.20
Enterprise Value/Revenue (TTM) 5.69
Price $230.11
Enterprise Value/EBITDA (TTM) 21.97
Enterprise Value/EBIT 27.73
Market Cap Category Large Cap
Dividends and Shares WST - NYSE Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 73.30M
Dividend Yield 0.36%
Div. Per Share (Most Recent) $0.21
Dividend Per Share (TTM) $0.82
Payout Ratio (TTM) 12.00%
Dividend Per Share (Most Recent) $0.21
Company Info WST - NYSE Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 610 594 2900
Address 530 Herman O. West Drive Exton, PA 19341-1147
Website www.westpharma.com
Country United States
Year Founded 1923
Profitability WST - NYSE Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) 20.51%
Profit Margin 17.02%
Management Effectiveness WST - NYSE Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets 9.93%
Return on Equity 17.71%
Income Statement WST - NYSE Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) 2.89B
Total Revenue (TTM) 2.89B
Revenue Per Share $39.47
Gross Profit (TTM) 998.50M
EBITDA (TTM) 749.00M
EBIT (TTM) 593.60M
Net Income (TTM) 492.70M
Net Income Avl. to Common (TTM) 492.70M
Total Revenue Growth (Q YOY) 2.30%
Earnings Growth (Q YOY) -5.04%
EPS Diluted (TTM) 6.69
EPS Diluted Growth (Q YOY) -2.10%
Balance Sheet WST - NYSE Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) 484.60M
Cash Per Share (Q) $6.61
Total Current Assets (Q) 1.54B
Total Preferred Equity (Q) --
Total Equity (Q) 2.68B
Current Ratio (Q) 2.795
Book Value Per Share (Q) $37.10
Total Assets (Q) 3.64B
Total Current Liabilities (Q) 550.40M
Total Debt (Q) 305.30M
Total Liabilities (Q) 961.10M
Total Common Equity (Q) 2.68B
Cash Flow WST - NYSE Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) -378.70M
Cash from Financing (TTM) -622.60M
Net Change in Cash (TTM) -369.30M
Levered Free Cash Flow (TTM) 206.23M
Cash from Operations (TTM) 653.40M
Weiss Ratings